NCT00279474 The Effect of Cognitive Behavior Intervention on Psychological Distress of Cancer Patients and Their Family Members Status UNKNOWN Phase NA
NCT00277069 Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00277017 Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00277004 Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer. Status TERMINATED Phase N/A
NCT00276003 INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma. Status COMPLETED Phase PHASE2
NCT00274885 Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer Status UNKNOWN Phase PHASE4
NCT00273546 Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00272662 Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy Status COMPLETED Phase PHASE2
NCT00270127 Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy Status COMPLETED Phase PHASE3
NCT00270049 Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00269763 Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer Status COMPLETED Phase PHASE3
NCT00269737 Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer Status COMPLETED Phase PHASE3
NCT00268905 A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00263783 Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00263575 Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients Status COMPLETED Phase PHASE3
NCT00262678 Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients. Status COMPLETED Phase PHASE3